| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a39744c21a453d217de1f61d7c1b79a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbe675b46d686407d64e31a937562663 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-326 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc4d35e82650fc6c4f8746f185d91dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9a695114cccceff1929c75d253a4f78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4926d0015f96f27280c6bd54a028afc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02505eee51339eea2b87ee2dbe9dd3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc0ae78ccdc4c7a8f13e1005bce54a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef71b64889f0eaca23d79f0f406d4cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c7a8d25cad9a3f8d1521e4d5ee31ce4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b25fbd4f7db0769ac7cdc1a3fef7d3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dbabce456d20c217c3a286d9502c3ea |
| publicationDate |
2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112021001798-A2 |
| titleOfInvention |
methods to assess atrial fibrillation, to diagnose heart failure, to aid in the assessment of atrial fibrillation, to predict stroke risk, and to improve prediction accuracy, uses, and kit |
| abstract |
The present invention relates to a method for assessing atrial fibrillation in a patient, said method comprising the steps of determining the amount of dkk3 in a patient sample and comparing the amount of dkk3 to a reference amount, wherein the atrial fibrillation should be evaluated. further, the present invention relates to a method for diagnosing heart failure and/or at least one structural or functional abnormality of the heart associated with heart failure. |
| priorityDate |
2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |